Electrolytic capacitor
    4.
    发明授权
    Electrolytic capacitor 失效
    电解电容器

    公开(公告)号:US4734821A

    公开(公告)日:1988-03-29

    申请号:US49297

    申请日:1987-05-13

    IPC分类号: H01G9/02 H01G9/022 H01G9/00

    CPC分类号: H01G9/022

    摘要: An electrolytic capacitor comprising a capacitor element and an electrolyte impregnated to the element, wherein the electrolyte comprises an organic polar solvent and a solute dissolved in the solvent, said solute being selected from the group consisting of a quaternary ammonium salt of an aromatic carboxylic acid, a quaternary ammonium salt of cycloalkene carboxylic acid and a quaternary ammonium salt of an unsaturated aliphatic carboxylic acid.

    摘要翻译: 一种电解电容器,包括电容器元件和浸渍到元件中的电解质,其中所述电解质包含有机极性溶剂和溶解在溶剂中的溶质,所述溶质选自芳族羧酸的季铵盐, 环烯烃羧酸的季铵盐和不饱和脂族羧酸的季铵盐。

    BLOOD INSULIN RESISTANCE AND DIABETES MARKER PROGRANULIN, METHOD FOR ANALYZING CONCENTRATION OF PROGRANULIN IN BLOOD SAMPLE, AND METHOD FOR SCREENING FOR SUBSTANCE THAT IMPROVES INSULIN RESISTANCE AND IMPROVES OR SUPPRESSES DIABETES
    10.
    发明申请
    BLOOD INSULIN RESISTANCE AND DIABETES MARKER PROGRANULIN, METHOD FOR ANALYZING CONCENTRATION OF PROGRANULIN IN BLOOD SAMPLE, AND METHOD FOR SCREENING FOR SUBSTANCE THAT IMPROVES INSULIN RESISTANCE AND IMPROVES OR SUPPRESSES DIABETES 审中-公开
    血清抗胰蛋白酶抗性和糖尿病标记物,用于分析血清样品浓度的方法,以及用于筛选改善胰岛素抵抗和改善或抑制糖尿病的物质的方法

    公开(公告)号:US20130210039A1

    公开(公告)日:2013-08-15

    申请号:US13819704

    申请日:2011-07-13

    IPC分类号: G01N33/68

    摘要: The present invention provides a marker capable of detecting insulin resistance and diabetes in a collected blood sample, a method for analyzing said marker, a method for screening a substance improving insulin resistance, and improving or suppressing diabetes. A blood insulin resistance marker and a blood diabetes marker, which comprises a polypeptide comprising at least 15 continuous amino acids in an amino acid sequence constituting progranulin. A method for analyzing a blood marker, which comprises the steps of: measuring a concentration of an insulin resistance marker or a diabetes marker in a collected blood sample; and comparing the measured concentration with a normal blood concentration of the marker. A method for screening a substance improving insulin resistance, and improving or suppressing diabetes, which comprises the steps of: administering a candidate substance to a living body expressing insulin resistance or suffering from diabetes; measuring a blood concentration of a marker in the living body after administration; and comparing the measured concentration of the marker with a blood concentration of the marker not administered with the candidate substance.

    摘要翻译: 本发明提供能够检测收集的血液样品中的胰岛素抵抗和糖尿病的标记物,分析所述标记物的方法,用于筛选改善胰岛素抵抗的物质的方法,以及改善或抑制糖尿病。 一种血液胰岛素抵抗标记物和血液糖尿病标志物,其包含在构成颗粒体蛋白前体的氨基酸序列中包含至少15个连续氨基酸的多肽。 一种分析血液标记物的方法,包括以下步骤:测量所收集的血液样品中胰岛素抵抗标志物或糖尿病标志物的浓度; 并将测量的浓度与标记物的正常血液浓度进行比较。 一种筛选改善胰岛素抵抗的物质,改善或抑制糖尿病的方法,包括以下步骤:将候选物质施用于表达胰岛素抵抗或患有糖尿病的活体; 测定给药后的生物体中的标记物的血液浓度; 并将标记物的测定浓度与未施用候选物质的标记物的血液浓度进行比较。